Financial statements Medallpharm
Balance sheet data of MEDALLPHARM
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 708 501,83 | 869 208,01 | 1 259 877,19 | 1 874 440,58 |
| A. Fixed assets | 87 473,86 | 71 441,46 | 55 409,06 | 264 176,71 |
| B. Current assets | 621 027,97 | 797 766,55 | 1 204 468,13 | 1 610 263,87 |
| C. Share capital contributions (basic funds) | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - |
| Total liabilities | 708 501,83 | 869 208,01 | 1 259 877,19 | 1 874 440,58 |
| A. Equity | 681 807,21 | 852 220,37 | 1 232 635,44 | 1 861 478,77 |
| B. Liabilities and provisions for liabilities | 26 694,62 | 16 987,64 | 27 241,75 | 12 961,81 |
| I. Long-term liabilities | - | - | - | - |
| II. Short-term liabilities | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.